Tetra Bio-Pharma ships inhaled cannabis drug QIKLEEF to US ahead of opioid comparision study …

REBORN1 will evaluate cannabis as an alternative to morphine sulfate immediate release , an opioid, in the management of breakthrough pain.

“We are committed to the fight against the opioid crisis,” Tetra Bio-Pharma CEO Guy Chamberland said in a statement.

The time to peak intensity of a breakthrough pain episode ranges from 3 to 15 minutes with a duration of 30 to 60 minutes, the company said.

Tetra Bio-Pharma Inc COO Steve Neron tells Proactive it has signed a letter of intent with Danish company DanCann Pharma for the exclusive distribution of its Reduvo Adversa and QIXLEEF products in Denmark, Norway, Sweden, Finland, and Germany.

…Read the full story